almagate has been researched along with Vitreous Hemorrhage in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, H; Borooah, S; Hegde, V; Mitry, D; Schmoll, C; Singh, J | 1 |
| Cohen, SY; Coscas, G; Creuzot-Garcher, C; Devin, F; Gaudric, A; Korobelnik, JF; Mauget-Faysse, M; Sahel, JA; Soubrane, G; Souied, E; Tadayoni, R; Weber, M | 1 |
| Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
| Larkin, G; Patel, N | 1 |
| Edmeades, N; Hornan, D; Khan, J; Krishnan, R; Lochhead, J | 1 |
| Acquah, K; Day, S; Grossman, DS; Lee, PP; Mruthyunjaya, P; Sloan, FA | 1 |
6 other study(ies) available for almagate and Vitreous Hemorrhage
| Article | Year |
|---|---|
Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis.
Topics: Aptamers, Nucleotide; Coagulants; Fluorescein Angiography; Humans; Male; Middle Aged; Retinal Vasculitis; Vision Disorders; Visual Acuity; Vitreous Hemorrhage | 2008 |
[Evolving intravitreous injection technique].
Topics: Adrenal Cortex Hormones; Antibiotic Prophylaxis; Aptamers, Nucleotide; Comorbidity; Contraindications; Drug Hypersensitivity; Eye Infections; Humans; Informed Consent; Injections; Macular Degeneration; Monitoring, Physiologic; Mydriatics; Practice Guidelines as Topic; Pupil; Retinal Artery Occlusion; Tonometry, Ocular; Unnecessary Procedures; Vitreous Body; Vitreous Hemorrhage | 2008 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |
Correspondence to case report titled: use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis.
Topics: Adult; Aptamers, Nucleotide; Coagulants; Humans; Male; Mycobacterium tuberculosis; Retinal Vasculitis; Tuberculosis; Vitreous Hemorrhage | 2009 |
Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Preoperative Care; Prospective Studies; Recurrence; Visual Acuity; Vitreous Hemorrhage | 2010 |
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Case-Control Studies; Endophthalmitis; Eye Diseases; Female; Follow-Up Studies; Health Services Research; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Male; Medicare Part B; Proportional Hazards Models; Ranibizumab; Retinal Detachment; Retinal Perforations; Retrospective Studies; United States; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Hemorrhage | 2011 |